Usefulness of health checkup‐based indices in identifying metabolic dysfunction‐associated steatotic liver disease

Documenti analoghi

• Usefulness of Retinol‐Binding Protein in Predicting Mortality in Patients With Chronic Liver Disease
  di: Yuki Utakata, et al.
  Pubblicazione: (2025)
• Dietary characteristics associated with the risk of non‐alcoholic fatty liver disease and metabolic dysfunction‐associated steatotic liver disease in non‐obese Japanese participants: A cross‐sectional study
  di: Hirokazu Taniguchi, et al.
  Pubblicazione: (2024)
• Low thyroid function is associated with metabolic dysfunction‐associated steatotic liver disease
  di: Shuo Wang, et al.
  Pubblicazione: (2024)
• Australians with metabolic dysfunction‐associated steatotic liver disease have a twofold increase in the incidence of cancer
  di: Elizabeth E Powell, et al.
  Pubblicazione: (2024)
• Impact of pemafibrate in patients with metabolic dysfunction‐associated steatotic liver disease complicated by dyslipidemia: A single‐arm prospective study
  di: Hiroki Ono, et al.
  Pubblicazione: (2024)